GENinCode (LON:GENI – Get Free Report) issued its earnings results on Monday. The company reported GBX (2.08) earnings per share (EPS) for the quarter, Digital Look Earnings reports. The business had revenue of GBX 308 million for the quarter. GENinCode had a negative net margin of 170.49% and a negative return on equity of 262.16%.
GENinCode Stock Up 5.3%
Shares of GENI opened at GBX 1 on Tuesday. The business’s 50 day moving average is GBX 1.13 and its 200 day moving average is GBX 1.54. The company has a market capitalization of £7.25 million, a PE ratio of -0.43 and a beta of 0.59. GENinCode has a 12-month low of GBX 0.90 and a 12-month high of GBX 5.50. The company has a current ratio of 2.80, a quick ratio of 15.89 and a debt-to-equity ratio of 7.17.
GENinCode Company Profile
GENinCode operates business units in the UK, in the United States through GENinCode U.S. Inc and in Europe through GENinCode S.L.U.
GENinCode predictive technology provides patients and physicians with globally leading preventative care and treatment strategies. GENinCode CE marked invitro-diagnostic molecular tests combine clinical algorithms and bioinformatics to provide advanced patient risk assessment to predict disease onset.
Read More
- Five stocks we like better than GENinCode
- Campbell’s Soup Stock: Deep Value and a 7% Dividend Yield
- 3 Stocks With Fresh Catalysts to Watch Before the July 4
- Amprius Insiders Are Selling: Should Investors Be Worried?
- A Weaker Dollar Could Put These 3 Industrial Stocks Back in Focus
Receive News & Ratings for GENinCode Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GENinCode and related companies with MarketBeat.com's FREE daily email newsletter.
